Psychopharmakotherapie in der stationären Medikamentenentzugsbehandlung - eine retrospektive Untersuchung der psychiatrischen Behandlungspraxis

Giller, Teresa

dc.contributor.advisor	Wedekind, Dirk PD Dr.
dc.contributor.author	Giller, Teresa
dc.date.accessioned	2016-11-10T10:08:23Z
dc.date.available	2016-11-22T23:50:05Z
dc.date.issued	2016-11-10
dc.identifier.uri	http://hdl.handle.net/11858/00-1735-0000-002B-7C9E-1
dc.identifier.uri	http://dx.doi.org/10.53846/goediss-5936
dc.identifier.uri	http://dx.doi.org/10.53846/goediss-5936
dc.language.iso	deu	de
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc	610	de
dc.title	Psychopharmakotherapie in der stationären Medikamentenentzugsbehandlung - eine retrospektive Untersuchung der psychiatrischen Behandlungspraxis	de
dc.type	doctoralThesis	de
dc.title.translated	Psychopharmacotherapy in the withdrawal treatment of inpatients with substance use disorder	de
dc.contributor.referee	Alt-Epping, Bernd Prof. Dr.
dc.date.examination	2016-11-15
dc.description.abstracteng	Despite the high clinical relevance, established guidelines for benzodiazepine-, and in particular opioid addiction are still scarce. In a retrospective design, treatment variables of inpatients with benzodiazepine- and opioid-addiction or abuse were recorded according to patients´ charts. Groups comprising patients with benzodiazepine/non-benzodiazepine abuse/addiction, opioid- and non-opioid analgetic abuse/addiction were established. 92% of all patients actually received additional pharmacologic treatment. Before all, antidepressants were prescribed (76%), but also mood-stabilizers/anticonvulsants (27%), and neuroleptic drugs (11%). Antidepressant treatment was tricyclic/tetracyclic treatment almost exclusively. Anticonvulsants, in most cases carbamazepine, was mostly prescribed for patients with combined drug use or high-dose benzodiazepine addiction, who were significantly more often treated with anticonvulsants compared to low-dose addicted subjects. Despite a negative recommendation according to AWMF-guidelines for medication addiction, low potential neuroleptic drugs were used frequently in all patient groups. 80% of included subjects had at least one comorbid psychiatric condition, before all depressive disorder, anxiety disorders, PTSD, and other adjustment disorders. 67% of patients described traumatic life-events. These were significantly more often found in high-dose compared to low dose benzodiazepine addicted patients.	de
dc.contributor.coReferee	Meyer, Thomas Prof. Dr.
dc.subject.ger	Benzodiazepin	de
dc.subject.ger	Opioidanalgetika	de
dc.subject.ger	Nichtopioidanalgetika	de
dc.subject.ger	Psychopharmakotherapie	de
dc.subject.ger	stationäre	de
dc.subject.ger	Medikamentenentzugsbehandlung	de
dc.subject.ger	Entzug	de
dc.subject.ger	Entzugsbehandlung	de
dc.subject.eng	substance	de
dc.subject.eng	opioid	de
dc.subject.eng	addiction	de
dc.subject.eng	benzodiazepine	de
dc.subject.eng	non-benzodiazepine	de
dc.subject.eng	abuse	de
dc.subject.eng	non-opioid	de
dc.subject.eng	withdrawal	de
dc.subject.eng	psychopharmacotherapy	de
dc.identifier.urn	urn:nbn:de:gbv:7-11858/00-1735-0000-002B-7C9E-1-5
dc.affiliation.institute	Medizinische Fakultät	de
dc.subject.gokfull	Medizin (PPN619874732)	de
dc.description.embargoed	2016-11-22
dc.identifier.ppn	872311821

Files in this item

Name:Doktorarbeit Teresa Giller.pdf

Size:1.685Mb

Format:PDF

View/Open

Name:: Doktorarbeit Teresa Giller.pdf
Size:: 1.685Mb
Format:: PDF

View/Open

This item appears in the following Collection(s)

Human- und Zahnmedizin [2987]

Show simple item record